Journal article
Adverse events with intravitreal injection of vascular endothelial growth factor inhibitors: nested case-control study
Abstract
OBJECTIVE: To assess the risk of systemic adverse events associated with intravitreal injections of vascular endothelial growth factor inhibiting drugs.
DESIGN: Population based nested case-control study.
Authors
Campbell RJ; Gill SS; Bronskill SE; Paterson JM; Whitehead M; Bell CM
Journal
The BMJ, Vol. 345, No. jul04 1,
Publisher
BMJ
Publication Date
July 4, 2012
DOI
10.1136/bmj.e4203
ISSN
0959-8138
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AgedAngiogenesis InhibitorsAntibodies, Monoclonal, HumanizedBevacizumabBrain IschemiaCase-Control StudiesFemaleHeart FailureHumansIntravitreal InjectionsLogistic ModelsMaleMyocardial InfarctionOntarioRanibizumabRetinal DiseasesRisk FactorsStrokeVascular Endothelial Growth Factor AVenous Thromboembolism